C.7C
NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
09/30/2021
Back to search
Official data from USPTO
PROMEDDX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
69
Latest update
09/30/2021
Trademark type
Combined
Nice classes
1, 39, 42
Filing date
06/26/2007
Registration date
06/01/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/03/2020
Last transaction
08/03/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/26/2007
First use in commerce
07/26/2007
Drawing code
3
Owner type
16
Owner location
BETHESDA, MD
Examiner
EDWARDS, ALICIA
Law office
M60
Current location
TMO LAW OFFICE 115
Mark description
The mark consists of the word "promeddx" in a stylized font.
Holders and representatives
Holders
PRECISION MEDICINE GROUP, LLC
ProMedDx LLC
ProMedDx LLC
Representatives
Donna H. Hartman OlenderFeldman LLP
Technical classification
Nice Classes
Class 1Class 39Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological tissuebloodblood plasmablood serumhuman tissuesglands and organs for scientific and medical research use
Class 39
Biomedical servicesstorage of human biological specimensbloodblood serumtissuesglands and organs for scientific and medical research use; shipping and packing of biological specimens; storage of human biological specimens for use in medical researchdevelopment and clinical trials conducted by companies in the in-vitro diagnosticspharmaceutical and biotechnology industries
Class 42
Clinical trial management services for the in-vitro diagnosticspharmaceutical and biotechnology industriesthe collection and handling of human biological specimens for use in medical researchdevelopment and clinical trials conducted by companies in the in-vitro diagnosticspharmaceutical and biotechnology industries
Publications
History of USPTO decisions and trademark events.
69 publications found
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/30/2021
ES7R
TEAS SECTION 7 REQUEST RECEIVED
05/02/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/07/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/07/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/07/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/03/2020
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/03/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/03/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/03/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
06/02/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/05/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/05/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/15/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/15/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/01/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/08/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/08/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/08/2016
E815
TEAS SECTION 8 & 15 RECEIVED
05/26/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/26/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/26/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
06/01/2010
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/27/2010
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
04/24/2010
ALIE
ASSIGNED TO LIE
04/24/2010
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/11/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/17/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/17/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/16/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/09/2010
GNRT
NON-FINAL ACTION E-MAILED
02/09/2010
CNRT
SU - NON-FINAL ACTION - WRITTEN
02/09/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/28/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/28/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/26/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/26/2009
GNRT
NON-FINAL ACTION E-MAILED
07/26/2009
CNRT
SU - NON-FINAL ACTION - WRITTEN
07/26/2009
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/30/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/30/2009
IUAF
USE AMENDMENT FILED
06/05/2009
EISU
TEAS STATEMENT OF USE RECEIVED
06/05/2009
DOCK
ASSIGNED TO EXAMINER
04/14/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
12/09/2008
PUBO
PUBLISHED FOR OPPOSITION
09/16/2008
NPUB
NOTICE OF PUBLICATION
08/27/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/13/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/05/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
08/05/2008
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/05/2008
GNEA
EXAMINERS AMENDMENT E-MAILED
08/05/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/05/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/27/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/27/2008
ALIE
ASSIGNED TO LIE
06/26/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2008
PETG
PETITION TO REVIVE-GRANTED
05/10/2008
PROA
TEAS PETITION TO REVIVE RECEIVED
05/10/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/20/2007
GNRT
NON-FINAL ACTION E-MAILED
10/20/2007
CNRT
NON-FINAL ACTION WRITTEN
10/20/2007
DOCK
ASSIGNED TO EXAMINER
09/26/2007
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
06/30/2007
NWAP
NEW APPLICATION ENTERED
06/29/2007
Continuous trademark protection
Get notified about every new filing that threatens PROMEDDX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.